Neurocrine Biosciences Inc (NAS:NBIX)
$ 136.53 -0.46 (-0.34%) Market Cap: 13.82 Bil Enterprise Value: 12.85 Bil PE Ratio: 36.60 PB Ratio: 5.08 GF Score: 88/100

Neurocrine Biosciences Inc at William Blair Biotech Focus Conference (Virtual) Transcript

Aug 06, 2020 / 04:00PM GMT
Release Date Price: $116.02 (-2.45%)
Timothy Francis Lugo
William Blair & Company L.L.C., Research Division - Co-Group Head of Biopharma Equity Research

Welcome to this year's Biotech Focus conference. It's our first virtual one, and I hope everyone on the webcast is safe and staying at least moderately, seeing these days. I know the weather is kind of a compounding issue out in the Northeast. So just my best wishes to everyone who's joined us.

And I will say, before we go to a partner discussion, our compliance would have a heart attack if I don't direct everyone to williamblair.com for a full list of disclosures. And just to start off, it's my pleasure to welcome all of our epilepsy panel members today. I've known some of you for years now, and it's always a pleasure to see progress in the field around epilepsy and the related disorders.

And it's my pleasure to welcome Jackie French from NYU Langone Health. She's also the Epilepsy Foundation member/queen/everything. And she also runs an incredibly informative pipeline focused conference, which myself and my team has attended for a number of years now. So I encourage

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot